158 related articles for article (PubMed ID: 21258357)
1. Combined prostaglandin E1 and lithium exert potent neuroprotection in a rat model of cerebral ischemia.
Sheng R; Zhang LS; Han R; Gao B; Liu XQ; Qin ZH
Acta Pharmacol Sin; 2011 Mar; 32(3):303-10. PubMed ID: 21258357
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia.
Han R; Gao B; Sheng R; Zhang LS; Zhang HL; Gu ZL; Qin ZH
Acta Pharmacol Sin; 2008 Oct; 29(10):1141-9. PubMed ID: 18817617
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia.
Xu XH; Zhang HL; Han R; Gu ZL; Qin ZH
Brain Res; 2006 Aug; 1102(1):154-62. PubMed ID: 16797496
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats.
Ling L; Zhang S; Ji Z; Huang H; Yao G; Wang M; He R; Deng W; Fang L
Int J Neurosci; 2016; 126(5):469-77. PubMed ID: 26000823
[TBL] [Abstract][Full Text] [Related]
5. Greater stress protein expression enhanced by combined prostaglandin A1 and lithium in a rat model of focal ischemia.
Xu XH; Hua YN; Zhang HL; Wu JC; Miao YZ; Han R; Gu ZL; Qin ZH
Acta Pharmacol Sin; 2007 Aug; 28(8):1097-104. PubMed ID: 17640469
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.
Kim HJ; Rowe M; Ren M; Hong JS; Chen PS; Chuang DM
J Pharmacol Exp Ther; 2007 Jun; 321(3):892-901. PubMed ID: 17371805
[TBL] [Abstract][Full Text] [Related]
7. [Lithium ascorbate as a cerebroprotective agent in a model of ischemic stroke].
Plotnikov EV; Litvak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):29-32. PubMed ID: 32307427
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
Xu J; Culman J; Blume A; Brecht S; Gohlke P
Stroke; 2003 May; 34(5):1287-92. PubMed ID: 12677021
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia.
Yang Q; Fang W; Lv P; Geng X; Li Y; Sha L
Pharmacology; 2012; 89(1-2):1-6. PubMed ID: 22178991
[TBL] [Abstract][Full Text] [Related]
10. Influence of groin incision, duration of ischemia, and prostaglandin E1 on ischemia-reperfusion injury of the lower limb.
Frässdorf J; Luther B; Müllenheim J; Otto F; Preckel B; Schlack W; Thämer V
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):187-95. PubMed ID: 16616658
[TBL] [Abstract][Full Text] [Related]
11. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
12. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 improves survival rate after 95% hepatectomy in rats.
Togo S; Chen H; Takahashi T; Kubota T; Matsuo K; Morioka D; Watanabe K; Yamamoto H; Nagashima Y; Shimada H
J Surg Res; 2008 May; 146(1):66-72. PubMed ID: 17599359
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
16. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.
Ren M; Senatorov VV; Chen RW; Chuang DM
Proc Natl Acad Sci U S A; 2003 May; 100(10):6210-5. PubMed ID: 12732732
[TBL] [Abstract][Full Text] [Related]
17. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
Li Q; Stephenson D
Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of prostaglandin E1 with somatostatin attenuates acute liver damage after massive hepatectomy in rats via inhibition of inflammatory responses, apoptosis and endoplasmic reticulum stress.
Jia C; Dai C; Bu X; Peng S; Xu F; Xu Y; Zhao Y
Int J Mol Med; 2013 Feb; 31(2):416-22. PubMed ID: 23242071
[TBL] [Abstract][Full Text] [Related]
20. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.
Schäbitz WR; Sommer C; Zoder W; Kiessling M; Schwaninger M; Schwab S
Stroke; 2000 Sep; 31(9):2212-7. PubMed ID: 10978054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
